MONDAY, April 24, 2023 (HealthDay News) — A two-drug combination therapy can enhance survival odds for people with early-stage liver cancer through targeted attacks on tumor cells, a new clinical trial shows. The combo — atezolizumab (Tecentriq) and bevacizumab (Avastin) — reduced risk of cancer recurrence or death by 28%Continue Reading

MONDAY, April 24, 2023 (HealthDay News) — When exercise studies are led by men, female participants are often in short supply. While this underrepresentation of female research subjects has been documented in everything from clinical trials to cell cultures, a new study links researchers’ gender and women’s participation. “Our findingsContinue Reading

Combo therapy may prevent cancer’s return after liver surgery. Atezolizumab and bevacizumab are already used together to treat advanced liver cancer, now a new study finds it does the same for early-stage disease. Read more This is your brain on books: Science unravels the secrets of reading. Recordings of brainContinue Reading

MONDAY, April 24, 2023 (HealthDay News) — Most people have heard of osteoarthritis and rheumatoid arthritis. But for some, psoriatic arthritis is the new kid on the block. Here’s what you need to know about psoriatic arthritis, including symptoms, types and treatments. What is psoriatic arthritis? Psoriatic arthritis (PsA), aContinue Reading